Literature DB >> 20095944

Liposomal cancer therapy: exploiting tumor characteristics.

Thomas Kaasgaard1, Thomas L Andresen.   

Abstract

IMPORTANCE OF THE FIELD: More than 10 million people worldwide are diagnosed with cancer each year, and the development of effective cancer treatments is consequently of great significance. Cancer therapy is unfortunately hampered by severe dose-limiting side effects that reduce the efficacy of cancer treatments. In the search for more effective cancer treatments, nanoparticle-based drug delivery systems, such as liposomes, that are capable of delivering their drug payload selectively to cancer cells are among the most promising approaches. AREAS COVERED IN THIS REVIEW: This review provides an overview of current strategies for improving the different stages of liposomal cancer therapy, which involve transporting drug-loaded liposomes through the bloodstream, increasing tumor accumulation, and improving drug release and cancer cell uptake after accumulation at the tumor target site. WHAT THE READER WILL GAIN: The review focuses on strategies that exploit characteristic features of solid tumors, such as abnormal vasculature, overexpression of receptors and enzymes, as well as acidic and thiolytic characteristics of the tumor microenvironment. TAKE HOME MESSAGE: It is concluded that the design of new liposomal drug delivery systems that better exploit tumor characteristic features is likely to result in more efficacious cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20095944     DOI: 10.1517/17425240903427940

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  24 in total

Review 1.  Developing therapeutic microRNAs for cancer.

Authors:  A G Bader; D Brown; J Stoudemire; P Lammers
Journal:  Gene Ther       Date:  2011-06-02       Impact factor: 5.250

Review 2.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

3.  Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.

Authors:  Gabriel Charest; Léon Sanche; David Fortin; David Mathieu; Benoit Paquette
Journal:  J Neurooncol       Date:  2013-09-13       Impact factor: 4.130

4.  Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.

Authors:  Gabriel Charest; Léon Sanche; David Fortin; David Mathieu; Benoit Paquette
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-26       Impact factor: 7.038

5.  Engineering building blocks for self-assembling protein nanoparticles.

Authors:  Esther Vázquez; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2010-12-30       Impact factor: 5.328

6.  Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.

Authors:  Hrushikesh Agashe; Kaustuv Sahoo; Pallavi Lagisetty; Vibhudutta Awasthi
Journal:  Colloids Surf B Biointerfaces       Date:  2011-01-25       Impact factor: 5.268

Review 7.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

Review 8.  Arsenic trioxide: insights into its evolution to an anticancer agent.

Authors:  Maneka Hoonjan; Vaibhav Jadhav; Purvi Bhatt
Journal:  J Biol Inorg Chem       Date:  2018-02-02       Impact factor: 3.358

Review 9.  Size matters: gold nanoparticles in targeted cancer drug delivery.

Authors:  Erik C Dreaden; Lauren A Austin; Megan A Mackey; Mostafa A El-Sayed
Journal:  Ther Deliv       Date:  2012-04

10.  Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid.

Authors:  Shravan Kumar Sriraman; Giusseppina Salzano; Can Sarisozen; Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2016-06-02       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.